Meyka AI API is live for developers.Start building.
Advertisement
Anteris Technologies Global Corp.

Anteris Technologies Global Corp. (AVR) Stock Overview

Explore Anteris Technologies Global Corp.’s financial performance, market position, analyst ratings, and future outlook.

AVRNASDAQ
HealthcareMedical - Devices
$9.64
$0.010(0.10%)
U.S. Market opens in 54h 57m
Advertisement

Anteris Technologies Global Corp. (AVR)

Meyka AI Score

Z

Key Financials

Market Cap354.6M
P/E Ratio-2.34
EPS (TTM)$-2.22
ROE-1.24%
Fundamental Analysis

AI Price Forecasts

1 Month$7.18
3 Months$7.93
1 Year Target$8.37

AVR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Anteris Technologies Global Corp. (AVR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 71.21, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $8.37.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.34 and a market capitalization of 354.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.10%
5-Day Change
10.68%
1-Month Change
55.74%
3-Month Change
52.29%
6-Month Change
106.42%
Year-to-Date (YTD) Change
93.19%
1-Year Change
94.35%
3-Year Change
72.14%
5-Year Change
72.14%
All-Time (Max) Change
72.14%

Contact Information

61 13 0055 0310
Toowong Tower, Toowong, QLD, 4066

Company Facts

136 Employees
IPO DateDec 13, 2024
CountryAU
Actively Trading

Frequently Asked Questions